NCT00114179View on ClinicalTrials.gov

Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
Interventions
DRUG

capecitabine

Given orally

RADIATION

radiation therapy

Undergo radiotherapy

BIOLOGICAL

bevacizumab

Given IV

PROCEDURE

therapeutic conventional surgery

Undergo surgery

DRUG

gemcitabine hydrochloride

Given IV

Trial Locations (1)

19103

Radiation Therapy Oncology Group, Philadelphia

Sponsors

Collaborators (1)

NRG Oncology
All Listed Sponsors
collaborator

NRG Oncology

OTHER

lead

National Cancer Institute (NCI)

NIH